Cargando…
The Role of Angiogenesis in Cancer Treatment
A number of anti-angiogenesis drugs have been FDA-approved and are being used in cancer treatment, and a number of other agents are in different stages of clinical development or in preclinical evaluation. However, pharmacologic anti-angiogenesis strategies that arrest tumor progression might not be...
Autores principales: | Rajabi, Mehdi, Mousa, Shaker A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489820/ https://www.ncbi.nlm.nih.gov/pubmed/28635679 http://dx.doi.org/10.3390/biomedicines5020034 |
Ejemplares similares
-
Evaluation of Angiogenesis Assays
por: Stryker, Zachary I., et al.
Publicado: (2019) -
Multifunctional Nanomaterials and Their Applications in Drug Delivery and Cancer Therapy
por: Srinivasan, Mathangi, et al.
Publicado: (2015) -
Correction: Godugu et al. Anti-Cancer Activities of Thyrointegrin α(v)β(3) Antagonist Mono- and Bis-Triazole Tetraiodothyroacetic Acid Conjugated via Polyethylene Glycols in Glioblastoma. Cancers 2021, 13, 2780
por: Godugu, Kavitha, et al.
Publicado: (2022) -
Anti-Cancer Activities of Thyrointegrin α(v)β(3) Antagonist Mono- and Bis-Triazole Tetraiodothyroacetic Acid Conjugated via Polyethylene Glycols in Glioblastoma
por: Godugu, Kavitha, et al.
Publicado: (2021) -
Thyroid Hormone-Induced Angiogenesis
por: Davis, Paul J, et al.
Publicado: (2009)